STOCK TITAN

Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

Inspira Technologies (NASDAQ: IINN) announces an upcoming live investor webinar and Q&A session scheduled for November 11, 2024, at 4:15 p.m. EST. The event, hosted by RedChip Companies, will feature company President Joe Hayon discussing innovative life support technology developments. The presentation will focus on their technology designed to monitor and improve declining blood oxygen saturation levels without mechanical ventilation, potentially disrupting the $19 billion mechanical ventilation market. Investors can register for free and submit questions in advance or during the event.

Inspira Technologies (NASDAQ: IINN) annuncia un imminente webinar dal vivo per gli investitori e una sessione di domande e risposte programmata per l'11 novembre 2024, alle 16:15 EST. L'evento, ospitato da RedChip Companies, vedrà il presidente dell'azienda, Joe Hayon, discutere degli sviluppi nella tecnologia innovativa per il supporto vitale. La presentazione si concentrerà sulla loro tecnologia progettata per monitorare e migliorare i livelli di saturazione di ossigeno nel sangue in declino senza ventilazione meccanica, potenzialmente in grado di interrompere il mercato della ventilazione meccanica da 19 miliardi di dollari. Gli investitori possono registrarsi gratuitamente e inviare domande in anticipo o durante l'evento.

Inspira Technologies (NASDAQ: IINN) anuncia un próximo seminario web en vivo para inversores y una sesión de preguntas y respuestas programada para el 11 de noviembre de 2024, a las 4:15 p.m. EST. El evento, organizado por RedChip Companies, contará con el presidente de la empresa, Joe Hayon, hablando sobre los desarrollos en tecnología innovadora de soporte vital. La presentación se centrará en su tecnología diseñada para monitorear y mejorar los niveles de saturación de oxígeno en sangre en declive sin ventilación mecánica, lo que podría interrumpir el mercado de ventilación mecánica de 19 mil millones de dólares. Los inversores pueden registrarse gratis y enviar preguntas con anticipación o durante el evento.

Inspira Technologies (NASDAQ: IINN)는 2024년 11월 11일 동부 표준시 오후 4시 15분에 예정된 라이브 투자자 웹세미나 및 질문과 답변 세션을 곧 개최한다고 발표했습니다. RedChip Companies가 주최하는 이번 이벤트에서는 회사의 사장인 Joe Hayon이 혁신적인 생명 유지 기술 개발에 대해 논의합니다. 발표는 기계적 환기 없이 혈중 산소 포화 농도가 감소하는 것을 모니터링하고 개선하기 위해 설계된 기술에 초점을 맞추며, 190억 달러 규모의 기계적 환기 시장을 파괴할 잠재력이 있습니다. 투자자는 무료로 등록하고 사전에 또는 이벤트 중에 질문을 제출할 수 있습니다.

Inspira Technologies (NASDAQ: IINN) annonce un prochain webinaire en direct pour les investisseurs et une session de questions-réponses prévue pour le 11 novembre 2024 à 16h15 EST. L'événement, animé par RedChip Companies, mettra en vedette le président de l'entreprise, Joe Hayon, qui discutera des développements en technologie de support vital innovante. La présentation se concentrera sur leur technologie conçue pour surveiller et améliorer les niveaux de saturation en oxygène dans le sang en déclin sans ventilation mécanique, ce qui pourrait potentiellement perturber le marché de la ventilation mécanique de 19 milliards de dollars. Les investisseurs peuvent s'inscrire gratuitement et soumettre des questions à l'avance ou pendant l'événement.

Inspira Technologies (NASDAQ: IINN) kündigt ein bevorstehendes Live-Webinar für Investoren sowie eine Frage-und-Antwort-Runde an, die für den 11. November 2024 um 16:15 Uhr EST geplant ist. Die Veranstaltung, die von RedChip Companies moderiert wird, wird den Präsidenten des Unternehmens, Joe Hayon, zeigen, der über innovative Technologien zur Unterstützung des Lebens spricht. Die Präsentation wird sich auf ihre Technologie konzentrieren, die darauf abzielt, abnehmende Werte der Blutsauerstoffsättigung ohne mechanische Beatmung zu überwachen und zu verbessern, was potenziell den 19-Milliarden-Dollar-Markt für mechanische Beatmung stören könnte. Investoren können sich kostenlos registrieren und im Voraus oder während der Veranstaltung Fragen einreichen.

Positive
  • Company is developing technology targeting a $19 billion market opportunity
  • Technology aims to provide alternative to mechanical ventilation for blood oxygen management
Negative
  • None.

RA'ANANA, Israel, Nov. 8, 2024 /PRNewswire/ -- Inspira Technologies Oxy B.H.N. Ltd. (NASDAQ: IINN), ("Inspira Technologies" or the "Company"), an innovative medical technology company in the life support and respiratory treatment arena, is pleased to invite investors to a webinar on November 11, 2024, at 4:15 p.m. EST.

 

Inspira Logo

 

The exclusive event, hosted by RedChip Companies, will feature Joe Hayon, President of Inspira Technologies, who will highlight the Company's developments, including its development of innovative life support technology, designed to monitor and elevate declining blood oxygen saturation levels in minutes without mechanical ventilation, that could disrupt the $19 billion mechanical ventilation market. A live Q&A session will follow the presentation.

To register for the free webinar, please visit:
https://redchip.zoom.us/webinar/register/WN_FDYYTg1DRV2SJPWn6DxEdQ#/registration

Questions can be pre-submitted to IINN@redchip.com or online during the live event.

About Inspira Technologies OXY B.H.N. Ltd.

Inspira™ Technologies is an innovative medical technology company in the life support and respiratory treatment arena. The Company has developed a breakthrough Augmented Respiration Technology (INSPIRA™ ART), a groundbreaking device poised to revolutionize the $19 billion mechanical ventilation market. With 20 million intensive care unit patients with acute respiratory failure each year, many of whom rely on mechanical ventilators, the INSPIRA™ ART offers a potential alternative by elevating and stabilizing decreasing oxygen saturation levels in minutes without a ventilator, with patient being awake during treatment. The INSPIRA ART is being equipped with clip-on HYLA™ blood sensor, a real-time continuous blood monitoring technology, aiming to alert physicians of changes in a patient's condition without the need for intermittent actual blood samples, and potentially supporting physicians in making informed decisions. For more information, visit https://inspira-technologies.com/investor-relations/. Any information displayed on, or that can be accessed through, our website or any other website or any social media is not a part of this press release.

Forward-Looking Statements
This press release contains express or implied forward-looking statements pursuant to U.S. Federal securities laws. These forward-looking statements and their implications are based on the current expectations of the management of the Company only and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. For example, the Company is using forward-looking statements when it discusses the potential size of its target market and that its development of innovative life support technology could disrupt the $19 billion mechanical ventilation market. These forward-looking statements and their implications are based solely on the current expectations of the Company's management and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Except as otherwise required by law, the Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. More detailed information about the risks and uncertainties affecting the Company is contained under the heading "Risk Factors" in the Company's annual report on Form 20-F for the fiscal year ended December 31, 2023 filed with the U.S. Securities and Exchange Commission (the "SEC"), which is available on the SEC's website, www.sec.gov.

Logo: https://mma.prnewswire.com/media/1668495/Inspira_Technologies_Logo.jpg

MRK-ARS-121
Copyright © 2018-2024 Inspira Technologies OXY B.H.N. LTD. All rights reserved.

Contact:
For more information, contact:
Inspira Technologies – Media Relations
Email: info@inspirao2.com
Phone: +972-9-9664485

Cision View original content:https://www.prnewswire.com/news-releases/join-inspira-technologies-live-investor-webinar-and-qa-session-on-november-11-302300001.html

SOURCE Inspira Technologies

FAQ

When is Inspira Technologies (IINN) hosting its investor webinar?

Inspira Technologies (IINN) is hosting its investor webinar on November 11, 2024, at 4:15 p.m. EST.

What market size is Inspira Technologies (IINN) targeting with its respiratory technology?

Inspira Technologies is targeting the $19 billion mechanical ventilation market with its innovative life support technology.

How can investors participate in Inspira Technologies' (IINN) November 2024 webinar?

Investors can register for free through the RedChip webinar link and can submit questions either in advance to IINN@redchip.com or during the live event.

Inspira Technologies Oxy B.H.N. Ltd. Ordinary Shares

NASDAQ:IINN

IINN Rankings

IINN Latest News

IINN Stock Data

26.10M
18.36M
8.88%
1.06%
0.52%
Medical Devices
Healthcare
Link
United States of America
Ra'anana